| Basics |
|
Sana Biotechnology, Inc.
|
| IPO Date: |
February 1, 2021 |
| Sector: |
Healthcare |
| Industry: |
Biotech |
| Market Cap: |
$1.37B |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.35 | 4.31%
|
| Avg Daily Range (30 D): |
$0.24 | 5.80%
|
| Avg Daily Range (90 D): |
$0.19 | 4.80%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
1.85M |
| Avg Daily Volume (30 D): |
4.17M |
| Avg Daily Volume (90 D): |
4.7M |
| Trade Size |
| Avg Trade Size (Sh.): |
141 |
| Avg Trade Size (Sh.) (30 D): |
180 |
| Avg Trade Size (Sh.) (90 D): |
203 |
| Institutional Trades |
| Total Inst.Trades: |
1,386 |
| Avg Inst. Trade: |
$1.84M |
| Avg Inst. Trade (30 D): |
$1.19M |
| Avg Inst. Trade (90 D): |
$1.31M |
| Avg Inst. Trade Volume: |
.25M |
| Avg Inst. Trades (Per Day): |
1 |
| Market Closing Trades |
| Avg Closing Trade: |
$1.97M |
| Avg Closing Trade (30 D): |
$1.21M |
| Avg Closing Trade (90 D): |
$1.4M |
| Avg Closing Volume: |
265.36K |
|
|
| Financials |
| |
TTM |
Q3 2025 |
Q2 2025 |
|
Basic EPS
|
$-.97
|
$-.16
|
$-.39
|
|
Diluted EPS
|
$-.97
|
$-.16
|
$-.39
|
|
Revenue
|
$ M
|
$ M
|
$ M
|
|
Gross Profit
|
$
|
$
|
$
|
|
Net Income / Loss
|
$ -234.41M
|
$ -42.15M
|
$ -93.8M
|
|
Operating Income / Loss
|
$ -239.99M
|
$ -43.52M
|
$ -94.98M
|
|
Cost of Revenue
|
$
|
$
|
$
|
|
Net Cash Flow
|
$ -23.28M
|
$ 32.09M
|
$ -24.86M
|
|
PE Ratio
|
|
|
|
|
|
|